A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction

Study Identifier
195263-006
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Dry Eye
  • Study Drug
  • AGN-195263 0.1%
  • AGN-195263 0.03%
  • AGN-195263 0.01%
  • AGN-195263 Vehicle
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    40+ years

    Protocol Summary

    This study will evaluate the safety and efficacy of AGN-195263 compared to vehicle in patients with meibomian gland dysfunction (MGD) in the eyelids.

    Study Locations

    Location
    Status
    Location
    Cornea Consultants of Arizona
    Phoenix, Arizona, United States, 85032
    Status
    Not applicable
    Location
    University of Arkansas for Medical
    Little Rock, Arkansas, United States, 72205
    Status
    Not applicable
    Location
    Sall Research Medical Center
    Artesia, California, United States, 90701
    Status
    Not applicable
    Location
    Orange County Ophthalmology Medical Group, Inc.
    Garden Grove, California, United States, 92843
    Status
    Not applicable
    Location
    Lugene Eye Institute
    Glendale, California, United States, 91205
    Status
    Not applicable
    Location
    Lakeside Vision Center
    Irvine, California, United States, 92604
    Status
    Not applicable
    Showing {first} - {last} of {total} Results